CYTOXAN Side Effects

7014793-0 | Cellulitis
on Sep 22, 2010 Female patient from UNITED STATES , 34 years of age, weighting 156.5 lb, was diagnosed with breast cancer (What is breast cancer?) and was treated with Cytoxan (View Usage). Patient experienced the following unwanted or unexpected effects: cellulitis (What is cellulitis?). Cytoxan dosage: . During the same period patient was treated with ADRIAMYCIN PFS (Third Cycle Started On 19-oct-2009) (View Adriamycin Pfs Review and Adriamycin Pfs Label ), AMBIEN (View Ambien Review and Ambien Label ), KLONOPIN (View Klonopin Review and Klonopin Label ), INDOCIN (View Indocin Review and Indocin Label ), PERCOCET (View Percocet Review and Percocet Label ), ZOLOFT (View Zoloft Review and Zoloft Label ). Patient was hospitalized.

7006692-5 | Acute Respiratory Distress Syndrome
Patient was taking Cytoxan (View Usage). Patient had the following side effects: acute respiratory distress syndrome on Sep 20, 2010 from FRANCE Additional patient health information: Female patient , 56 years of age, was diagnosed with breast cancer (What is breast cancer?) and. Cytoxan dosage: 1500mg:26may10 1500mg:23jun10 1400mg:14jul10 1400mg:04aug10. During the same period patient was treated with TAXOTERE (180mg:26may10 185mg:23jun10 180mg:14jul10 175mg:04aug10) (View Taxotere Review and Taxotere Label ). Patient was hospitalized.

7004969-0 | Abdominal Pain
Adverse event was reported on Sep 20, 2010 by a Female patient taking Cytoxan (View Usage) (Dosage: ) . Location: UNITED STATES , 39 years of age, weighting 183.4 lb, After Cytoxan was administered, patient had the following side effects: abdominal pain (What is abdominal pain?). During the same period patient was treated with ACTINOMYCIN (View Actinomycin Review and Actinomycin Label ). Patient was hospitalized.

6915621-1 | Enteritis, Ileus
on Aug 03, 2010 Female patient from UNITED STATES , 40 years of age, was diagnosed with breast cancer (What is breast cancer?) and was treated with Cytoxan (View Usage). Patient experienced the following unwanted or unexpected effects: enteritis, ileus. Cytoxan dosage: . During the same period patient was treated with TAXOTERE (Every Cycle) (View Taxotere Review and Taxotere Label ).


6813321-X | Renal Failure Acute
on Jun 27, 2010 Female patient from GERMANY , 78 years of age, was diagnosed with breast cancer (What is breast cancer?), prophylaxis and was treated with Cytoxan (View Usage). Patient had the following side effects: renal failure acute. Cytoxan dosage: . During the same period patient was treated with CIPRO (View Cipro Review and Cipro Label ), TAXOTERE (View Taxotere Review and Taxotere Label ), DECADRON (View Decadron Review and Decadron Label ), ALOXI (View Aloxi Review and Aloxi Label ), EMEND (View Emend Review and Emend Label ), NEULASTA (View Neulasta Review and Neulasta Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ).

6796419-4 | Amenorrhoea, Migraine
Patient was taking Cytoxan (View Usage). After Cytoxan was administered, patient had the following side effects: amenorrhoea, migraine (What is migraine?) on Jun 21, 2010 from UNITED STATES Additional patient health information: Female patient , 32 years of age, was diagnosed with breast cancer (What is breast cancer?) and. Cytoxan dosage: 8 Cycles Of 4 Combined Regimens Of Adriamycin And Cytoxan. During the same period patient was treated with TAXOL (4 Regimen Of Taxol Over 16 Wk.) (View Taxol Review and Taxol Label ), ADRIAMYCIN PFS (8 Cycles Of 4 Combined Regimens Of Adriamycin And Cytoxan) (View Adriamycin Pfs Review and Adriamycin Pfs Label ).

6747565-2 | Pneumocystis Jiroveci Pneumonia, Pulmonary Embolism
Adverse event was reported on May 24, 2010 by a Female patient taking Cytoxan (View Usage) (Dosage: ) was diagnosed with breast cancer (What is breast cancer?) and. Location: UNITED STATES , 61 years of age, Patient experienced the following unwanted or unexpected effects: pneumocystis jiroveci pneumonia, pulmonary embolism (What is pulmonary embolism?). During the same period patient was treated with PACLITAXEL (View Paclitaxel Review and Paclitaxel Label ), ADRIAMYCIN PFS (View Adriamycin Pfs Review and Adriamycin Pfs Label ).

6742537-6 | Rash Pruritic
on Nov 19, 2009 Female patient from UNITED STATES , 53 years of age, was diagnosed with breast cancer metastatic and was treated with Cytoxan (View Usage). Patient had the following side effects: rash pruritic. Cytoxan dosage: ;every 3 Wk;iv. During the same period patient was treated with TAXOTERE (;every 3 Wk;iv) (View Taxotere Review and Taxotere Label ), NEUPOGEN (View Neupogen Review and Neupogen Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ). Patient was hospitalized.

6742536-4 | Febrile Neutropenia
on Jun 16, 2009 Female patient from UNITED STATES , 64 years of age, weighting 159.2 lb, was diagnosed with breast cancer (What is breast cancer?) and was treated with Cytoxan (View Usage). After Cytoxan was administered, patient had the following side effects: febrile neutropenia. Cytoxan dosage: 1140 Mg;every 3 Wk;iv. During the same period patient was treated with ADRIAMYCIN PFS (114 Mg;every 3 Wk;iv) (View Adriamycin Pfs Review and Adriamycin Pfs Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), ATORVASTATIN CALCIUM (View Atorvastatin Calcium Review and Atorvastatin Calcium Label ), PLAQUENIL (View Plaquenil Review and Plaquenil Label ), AMITRIPTYLINE (View Amitriptyline Review and Amitriptyline Label ), PANTOPRAZOLE SODIUM (View Pantoprazole Sodium Review and Pantoprazole Sodium Label ), PAXIL (View Paxil Review and Paxil Label ), VALIUM (View Valium Review and Valium Label ). Patient was hospitalized.

6742522-4 | Nausea
Patient was taking Cytoxan (View Usage). Patient experienced the following unwanted or unexpected effects: nausea (What is nausea?) on Apr 16, 2009 from UNITED STATES Additional patient health information: Female patient , 66 years of age, weighting 178.0 lb, was diagnosed with breast cancer (What is breast cancer?) and. Cytoxan dosage: 1104 Mg; Iv. During the same period patient was treated with ADRIAMYCIN PFS (110 Mg; Iv) (View Adriamycin Pfs Review and Adriamycin Pfs Label ). Patient was hospitalized.

6703668-X | Caecitis, Gastrointestinal Necrosis, Intestinal Perforation, Sepsis, Septic Shock, White Blood Cell Count Decreased
Adverse event was reported on Apr 27, 2010 by a Female patient taking Cytoxan (View Usage) (Dosage: ) was diagnosed with breast cancer (What is breast cancer?) and. Location: UNITED STATES , 49 years of age, weighting 132.3 lb, Patient had the following side effects: caecitis, gastrointestinal necrosis, intestinal perforation, sepsis (What is sepsis?), septic shock, white blood cell count decreased. During the same period patient was treated with ADRIAMYCIN PFS (View Adriamycin Pfs Review and Adriamycin Pfs Label ), TAXOTERE (1df=80mg Vial(exp:31aug2012)+60mg Vial(exp:30jun2011)-a Total Dose Of 125mg) (View Taxotere Review and Taxotere Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), NEULASTA (View Neulasta Review and Neulasta Label ), EMEND (View Emend Review and Emend Label ), ZOFRAN (View Zofran Review and Zofran Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ), COMPAZINE (View Compazine Review and Compazine Label ). Patient was hospitalized.

6698902-9 | Angioedema, No Therapeutic Response, Pruritus, Throat Tightness
on Apr 26, 2010 Female patient from UNITED STATES , weighting 147.0 lb, was diagnosed with breast cancer (What is breast cancer?) and was treated with Cytoxan (View Usage). After Cytoxan was administered, patient had the following side effects: angioedema, no therapeutic response, pruritus, throat tightness. Cytoxan dosage: 985mg Q3week Iv. During the same period patient was treated with NEULASTA (985mg Q3week Iv) (View Neulasta Review and Neulasta Label ), TAXOTERE (125mg Q3week Iv) (View Taxotere Review and Taxotere Label ).

6670313-1 | Blood Lactate Dehydrogenase Increased, Dehydration, Diarrhoea, Hepatic Enzyme Increased, Palmar-plantar Erythrodysaesthesia Syndrome
on Mar 31, 2010 Female patient from FRANCE , 77 years of age, was treated with Cytoxan (View Usage). Patient experienced the following unwanted or unexpected effects: blood lactate dehydrogenase increased, dehydration, diarrhoea, hepatic enzyme increased, palmar-plantar erythrodysaesthesia syndrome. Cytoxan dosage: . During the same period patient was treated with TAXOTERE (View Taxotere Review and Taxotere Label ), INSULIN (View Insulin Review and Insulin Label ), ADRIAMYCIN PFS (View Adriamycin Pfs Review and Adriamycin Pfs Label ). Patient was hospitalized.

6657321-1 | Asthenia, Blood Potassium Decreased, Dizziness, Neutropenia, Platelet Count Decreased, Presyncope, Vision Blurred
Patient was taking Cytoxan (View Usage). Patient had the following side effects: asthenia, blood potassium decreased, dizziness (What is dizziness?), neutropenia, platelet count decreased, presyncope, vision blurred on Mar 22, 2010 from UNITED STATES Additional patient health information: Female patient , 60 years of age, was diagnosed with multiple myeloma (What is multiple myeloma?) and. Cytoxan dosage: Day 1 And 8 Every 21 Days Taken As Conmed Also. During the same period patient was treated with REVLIMID (8days;interrupted On 04jan2010) (View Revlimid Review and Revlimid Label ), VELCADE (Day 1 And 8 Every 21days Taken As Conmed Also) (View Velcade Review and Velcade Label ), DECADRON (Day1 And 8 Taken As Conmed Also) (View Decadron Review and Decadron Label ).

6644287-3 | Cerebral Infarction, Cerebrovascular Accident, Cough, Dyspnoea, Pulmonary Toxicity
Adverse event was reported on Mar 19, 2010 by a Female patient taking Cytoxan (View Usage) (Dosage: ? Of 3 Weekly Iv, Completed Cemo Course) was diagnosed with breast cancer (What is breast cancer?) and. Location: UNITED STATES , 73 years of age, After Cytoxan was administered, patient had the following side effects: cerebral infarction, cerebrovascular accident, cough, dyspnoea, pulmonary toxicity. During the same period patient was treated with RANITIDINE (View Ranitidine Review and Ranitidine Label ), ACEPHEX (View Acephex Review and Acephex Label ), EVISTA (View Evista Review and Evista Label ), BACTRIM (View Bactrim Review and Bactrim Label ), M.V.I. (View M.v.i. Review and M.v.i. Label ), VIT D (View Vit D Review and Vit D Label ), POTASSIUM CHLORIDE (View Potassium Chloride Review and Potassium Chloride Label ), CODEINE (PHENERGAN (View Codeine (phenergan Review and Codeine (phenergan Label ).

6618771-2 | Anaemia, Decreased Appetite, Dehydration, Epistaxis, Fatigue, Febrile Neutropenia, Nausea, Pyrexia, Sinusitis
on Feb 25, 2010 Female patient from UNITED STATES , 61 years of age, weighting 132.3 lb, was diagnosed with breast cancer (What is breast cancer?) and was treated with Cytoxan (View Usage). Patient experienced the following unwanted or unexpected effects: anaemia, decreased appetite, dehydration, epistaxis, fatigue, febrile neutropenia, nausea (What is nausea?), pyrexia, sinusitis (What is sinusitis?). Cytoxan dosage: . During the same period patient was treated with AVASTIN (View Avastin Review and Avastin Label ), ADRIAMYCIN PFS (View Adriamycin Pfs Review and Adriamycin Pfs Label ), ABRAXANE (View Abraxane Review and Abraxane Label ), NEULASTA (View Neulasta Review and Neulasta Label ). Patient was hospitalized.

6618760-8 | Unevaluable Event
on Mar 05, 2010 Female patient from UNITED STATES , weighting 132.3 lb, was diagnosed with t-cell lymphoma stage iv and was treated with Cytoxan (View Usage). Patient had the following side effects: unevaluable event. Cytoxan dosage: See B-6 See B-6 Iv. Patient was hospitalized and became disabled.

6509486-X | Dehydration, Hypophosphataemia, Neutropenia, Pneumonia
Patient was taking Cytoxan (View Usage). After Cytoxan was administered, patient had the following side effects: dehydration, hypophosphataemia, neutropenia, pneumonia (What is pneumonia?) on Dec 15, 2009 from UNITED STATES Additional patient health information: Male patient , 69 years of age, was diagnosed with multiple myeloma (What is multiple myeloma?), pleural effusion and. Cytoxan dosage: . During the same period patient was treated with REVLIMID (Formulation:caps Interrupted On 21sep09) (View Revlimid Review and Revlimid Label ), VELCADE (On 18jun09:244 Mg) (View Velcade Review and Velcade Label ), LASIX (View Lasix Review and Lasix Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), DEXAMETHASONE TAB (1 Df=4 Unit Nos) (View Dexamethasone Tab Review and Dexamethasone Tab Label ), DIFLUCAN (1df=200 Unit Nos) (View Diflucan Review and Diflucan Label ), LOPRESSOR (1 Df=200 Unit Nos) (View Lopressor Review and Lopressor Label ), MAGNESIUM CITRATE (1 Df=1 Bottle) (View Magnesium Citrate Review and Magnesium Citrate Label ). Patient was hospitalized.

6506414-8 | Hepatic Failure, Necrotising Colitis, Renal Failure, Respiratory Failure
Adverse event was reported on Dec 15, 2009 by a Female patient taking Cytoxan (View Usage) (Dosage: ) was diagnosed with breast cancer stage ii and. Location: FRANCE , 62 years of age, Patient experienced the following unwanted or unexpected effects: hepatic failure, necrotising colitis, renal failure, respiratory failure. During the same period patient was treated with TAXOTERE (View Taxotere Review and Taxotere Label ), ACTOS (View Actos Review and Actos Label ), COUMADIN (View Coumadin Review and Coumadin Label ), DIOVAN (View Diovan Review and Diovan Label ), GLUCOPHAGE (View Glucophage Review and Glucophage Label ), JANUVIA (View Januvia Review and Januvia Label ), LASIX (View Lasix Review and Lasix Label ), LYRICA (View Lyrica Review and Lyrica Label ).

6470416-0 | Bronchitis, Dyspnoea, Haemoglobin Decreased, Malaise, Oedema Peripheral, Platelet Count Decreased, White Blood Cell Count Decreased
on Dec 01, 2009 Female patient from UNITED STATES , 72 years of age, was diagnosed with multiple myeloma (What is multiple myeloma?) and was treated with Cytoxan (View Usage). Patient had the following side effects: bronchitis (What is bronchitis?), dyspnoea, haemoglobin decreased, malaise, oedema peripheral, platelet count decreased, white blood cell count decreased. Cytoxan dosage: Day 1,8,15 And 21, Unk-2009. During the same period patient was treated with REVLIMID (Stopped In Jun07 Restarted On 27apr09, Int On 07aug09 And Restarted On 02oct09, Dailyx21 Days) (View Revlimid Review and Revlimid Label ), DEXAMETHASONE TAB (Restarted On 02oct09, Day 1-4, 12-15) (View Dexamethasone Tab Review and Dexamethasone Tab Label ), SOTALOL HCL (View Sotalol Hcl Review and Sotalol Hcl Label ), BENICAR (View Benicar Review and Benicar Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), PRILOSEC (View Prilosec Review and Prilosec Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), CELEBREX (View Celebrex Review and Celebrex Label ).

6460819-2 | Hypercalcaemia, Hyponatraemia, Malignant Neoplasm Progression
on Nov 25, 2009 Female patient from UNITED STATES , weighting 168.4 lb, was diagnosed with ovarian cancer and was treated with Cytoxan (View Usage). After Cytoxan was administered, patient had the following side effects: hypercalcaemia, hyponatraemia, malignant neoplasm progression. Cytoxan dosage: 50 Mg Daily Po. During the same period patient was treated with AMIODARONE HCL (View Amiodarone Hcl Review and Amiodarone Hcl Label ), HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), POTASSIUM CHLORIDE (View Potassium Chloride Review and Potassium Chloride Label ), ATENOLOL (View Atenolol Review and Atenolol Label ).

6458608-8 | Capillary Leak Syndrome
Patient was taking Cytoxan (View Usage). Patient experienced the following unwanted or unexpected effects: capillary leak syndrome on Nov 19, 2009 from FRANCE Additional patient health information: Female patient , 52 years of age, weighting 176.4 lb, was diagnosed with breast cancer (What is breast cancer?) and. Cytoxan dosage: . During the same period patient was treated with TAXOTERE (Parenteral Conc For Soln For Inf Iv - 14sep09-14sep09 13jul09-13jul09) (View Taxotere Review and Taxotere Label ).

6457733-5 | Anosmia
Adverse event was reported on Nov 23, 2009 by a Female patient taking Cytoxan (View Usage) (Dosage: ) was diagnosed with breast cancer (What is breast cancer?) and. Location: UNITED STATES , 72 years of age, weighting 160.9 lb, Patient had the following side effects: anosmia. During the same period patient was treated with ADRIAMYCIN PFS (View Adriamycin Pfs Review and Adriamycin Pfs Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ).

6450381-2 | Intestinal Perforation, Sepsis
on Nov 16, 2009 Female patient from FRANCE , 50 years of age, was diagnosed with breast cancer stage i and was treated with Cytoxan (View Usage). After Cytoxan was administered, patient had the following side effects: intestinal perforation, sepsis (What is sepsis?). Cytoxan dosage: . During the same period patient was treated with TAXOTERE (View Taxotere Review and Taxotere Label ).

6448454-3 | Febrile Neutropenia, Mucosal Inflammation, Oral Candidiasis, Perirectal Abscess
on Nov 19, 2009 Female patient from UNITED STATES , 80 years of age, weighting 151.7 lb, was diagnosed with b-cell lymphoma and was treated with Cytoxan (View Usage). Patient experienced the following unwanted or unexpected effects: febrile neutropenia, mucosal inflammation, oral candidiasis, perirectal abscess. Cytoxan dosage: 750 Mg/m2, Once, Iv. During the same period patient was treated with ADRIAMYCIN (PART OF R CHOP + LEUKINE REGIMEN) (50 Mg/m2, Once, Iv) (View Adriamycin (part Of R-chop + Leukine Regimen) Review and Adriamycin (part Of R-chop + Leukine Regimen) Label ), COLACE (View Colace Review and Colace Label ), TYLENOL (CAPLET) (View Tylenol (caplet) Review and Tylenol (caplet) Label ), ANZEMET (View Anzemet Review and Anzemet Label ), BENADRYL (View Benadryl Review and Benadryl Label ), DULCOLAX (View Dulcolax Review and Dulcolax Label ), PRILOSEC (View Prilosec Review and Prilosec Label ). Patient was hospitalized.

6448453-1 | Oral Candidiasis, Stomatitis
Patient was taking Cytoxan (View Usage). Patient had the following side effects: oral candidiasis, stomatitis on Nov 19, 2009 from UNITED STATES Additional patient health information: Female patient , 75 years of age, weighting 106.3 lb, was diagnosed with b-cell lymphoma and. Cytoxan dosage: 750 Mg/m2, Once, Iv. During the same period patient was treated with ADRIAMYCIN (PART OF R CHOP + LEUKINE REGIMEN) (50 Mg/m2, Once, Iv) (View Adriamycin (part Of R-chop + Leukine Regimen) Review and Adriamycin (part Of R-chop + Leukine Regimen) Label ). Patient was hospitalized.

6448452-X | Dehydration, Hypophagia, Mucosal Inflammation, Neutropenia, Orthostatic Hypotension
Adverse event was reported on Nov 19, 2009 by a Male patient taking Cytoxan (View Usage) (Dosage: 562.5 Mg/m2, Once, Iv) was diagnosed with b-cell lymphoma and. Location: UNITED STATES , 68 years of age, weighting 162.0 lb, After Cytoxan was administered, patient had the following side effects: dehydration, hypophagia, mucosal inflammation, neutropenia, orthostatic hypotension. During the same period patient was treated with ADRIAMYCIN (PART OF R CHOP + LEUKINE REGIMEN) (37.5 Mg/m2, Once, Iv) (View Adriamycin (part Of R-chop + Leukine Regimen) Review and Adriamycin (part Of R-chop + Leukine Regimen) Label ). Patient was hospitalized.

6448433-6 | Candidiasis, Flank Pain, Mucosal Inflammation, Neutropenia, Oesophageal Candidiasis
on Nov 19, 2009 Male patient from UNITED STATES , 68 years of age, weighting 179.9 lb, was diagnosed with b-cell lymphoma and was treated with Cytoxan (View Usage). Patient experienced the following unwanted or unexpected effects: candidiasis, flank pain, mucosal inflammation, neutropenia, oesophageal candidiasis. Cytoxan dosage: 750 Mg/m2, Once, Iv. During the same period patient was treated with ADRIAMYCIN PFS (50 Mg/m2, Once, Iv) (View Adriamycin Pfs Review and Adriamycin Pfs Label ). Patient was hospitalized.

6442868-3 | Cellulitis
on Nov 11, 2009 Female patient from UNITED STATES , 34 years of age, weighting 156.5 lb, was diagnosed with breast cancer (What is breast cancer?) and was treated with Cytoxan (View Usage). Patient had the following side effects: cellulitis (What is cellulitis?). Cytoxan dosage: . During the same period patient was treated with ADRIAMYCIN PFS (Third Cycle Started On 19-oct-2009) (View Adriamycin Pfs Review and Adriamycin Pfs Label ), AMBIEN (View Ambien Review and Ambien Label ), KLONOPIN (View Klonopin Review and Klonopin Label ), INDOCIN (View Indocin Review and Indocin Label ), PERCOCET (View Percocet Review and Percocet Label ), ZOLOFT (View Zoloft Review and Zoloft Label ). Patient was hospitalized.

6422761-2 | Cellulitis
Patient was taking Cytoxan (View Usage). After Cytoxan was administered, patient had the following side effects: cellulitis (What is cellulitis?) on Oct 27, 2009 from UNITED STATES Additional patient health information: Female patient , 34 years of age, weighting 156.5 lb, was diagnosed with breast cancer (What is breast cancer?) and. Cytoxan dosage: . During the same period patient was treated with ADRIAMYCIN PFS (Third Cycle Started On 19-oct-2009) (View Adriamycin Pfs Review and Adriamycin Pfs Label ), AMBIEN (View Ambien Review and Ambien Label ), KLONOPIN (View Klonopin Review and Klonopin Label ), INDOCIN (View Indocin Review and Indocin Label ), PERCOCET (View Percocet Review and Percocet Label ), ZOLOFT (View Zoloft Review and Zoloft Label ). Patient was hospitalized.

6410541-3 | Dehydration, Hypophosphataemia, Neutropenia, Pneumonia
Adverse event was reported on Oct 19, 2009 by a Male patient taking Cytoxan (View Usage) (Dosage: ) was diagnosed with multiple myeloma (What is multiple myeloma?), pleural effusion and. Location: UNITED STATES , 69 years of age, Patient experienced the following unwanted or unexpected effects: dehydration, hypophosphataemia, neutropenia, pneumonia (What is pneumonia?). During the same period patient was treated with REVLIMID (Formulation:caps Interrupted On Jun09) (View Revlimid Review and Revlimid Label ), LASIX (View Lasix Review and Lasix Label ), VELCADE (On 18jun09:244 Mg) (View Velcade Review and Velcade Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), DEXAMETHASONE (1 Df=4 Unit Nos) (View Dexamethasone Review and Dexamethasone Label ), DIFLUCAN (1df=200 Unit Nos) (View Diflucan Review and Diflucan Label ), LOPRESSOR (1 Df=200 Unit Nos) (View Lopressor Review and Lopressor Label ), MAGNESIUM CITRATE (1 Df=1 Bottle) (View Magnesium Citrate Review and Magnesium Citrate Label ). Patient was hospitalized.

6380963-8 | Haemoptysis, Pneumonia, Productive Cough
on Sep 25, 2009 Male patient from UNITED STATES , 68 years of age, weighting 269.0 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Cytoxan (View Usage). Patient had the following side effects: haemoptysis, pneumonia (What is pneumonia?), productive cough. Cytoxan dosage: 750mg/m2 Iv Day 1. During the same period patient was treated with ADRIAMYCIN PFS (50mg/m2 Iv Day 1) (View Adriamycin Pfs Review and Adriamycin Pfs Label ), VINCRISTINE (1.4mg/m2 Iv Day 1) (View Vincristine Review and Vincristine Label ), PREDNISONE TAB (View Prednisone Tab Review and Prednisone Tab Label ), NEULASTA (View Neulasta Review and Neulasta Label ). Patient was hospitalized.

6380812-8 | Febrile Neutropenia
on Sep 25, 2009 Male patient from UNITED STATES , 68 years of age, weighting 268.0 lb, was diagnosed with non-hodgkin's lymphoma and was treated with Cytoxan (View Usage). After Cytoxan was administered, patient had the following side effects: febrile neutropenia. Cytoxan dosage: 750mg/m2 Iv Day 1. During the same period patient was treated with ADRIAMYCIN PFS (50mg/m2 Iv Day 1) (View Adriamycin Pfs Review and Adriamycin Pfs Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), NEULASTA (View Neulasta Review and Neulasta Label ). Patient was hospitalized.

6330610-6 | Capillary Leak Syndrome
Patient was taking Cytoxan (View Usage). Patient experienced the following unwanted or unexpected effects: capillary leak syndrome on Aug 24, 2009 from UNITED STATES Additional patient health information: Female patient , 64 years of age, was diagnosed with breast cancer (What is breast cancer?) and. Cytoxan dosage: . During the same period patient was treated with TAXOTERE (Solution For Infusion) (View Taxotere Review and Taxotere Label ), HERCEPTIN (Administered 1 Dose.) (View Herceptin Review and Herceptin Label ). Patient was hospitalized.

6237214-4 | Dehydration, Febrile Neutropenia, Tachycardia
Adverse event was reported on Jun 18, 2009 by a Female patient taking Cytoxan (View Usage) (Dosage: ) was diagnosed with breast cancer (What is breast cancer?) and. Location: UNITED STATES , 49 years of age, weighting 127.9 lb, Patient had the following side effects: dehydration, febrile neutropenia, tachycardia. During the same period patient was treated with ADRIAMYCIN RDF (Solution For Injection) (View Adriamycin Rdf Review and Adriamycin Rdf Label ), HYDROCODONE BITARTRATE (View Hydrocodone Bitartrate Review and Hydrocodone Bitartrate Label ), PROTONIX (View Protonix Review and Protonix Label ), PHENERGAN (View Phenergan Review and Phenergan Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), PRILOSEC (View Prilosec Review and Prilosec Label ), ZESTORETIC (View Zestoretic Review and Zestoretic Label ), TRAZODONE HCL (View Trazodone Hcl Review and Trazodone Hcl Label ). Patient was hospitalized.

6207044-8 | Asthenia, Chills, Diarrhoea, Febrile Neutropenia, Nausea
on Jan 23, 2009 Female patient from UNITED STATES , 56 years of age, weighting 124.0 lb, was diagnosed with breast cancer (What is breast cancer?) and was treated with Cytoxan (View Usage). After Cytoxan was administered, patient had the following side effects: asthenia, chills, diarrhoea, febrile neutropenia, nausea (What is nausea?). Cytoxan dosage: 925 Mg; Every 2 Wk; Iv, 970 Mg; Every 2 Wk; Iv. During the same period patient was treated with ADRIAMYCIN RDF (92 Mg; Every 2 Wk; Ivdri 100 Mg; Every 2 Wk; Ivdri) (View Adriamycin Rdf Review and Adriamycin Rdf Label ), BEVACIZUMAB (570 Mg; Every 2 Wk; Ivdri, 615 Mg; Every 2 Wk; Ivdri) (View Bevacizumab Review and Bevacizumab Label ), NEULASTA (6 Mg; Every 2 Wk; Sc, 6 Mg; Every 2 Hr; Sc) (View Neulasta Review and Neulasta Label ), LEVAQUIN (View Levaquin Review and Levaquin Label ). Patient was hospitalized.

6207032-1 | Pancytopenia
on Mar 31, 2009 Female patient from UNITED STATES , 50 years of age, was diagnosed with breast cancer (What is breast cancer?) and was treated with Cytoxan (View Usage). Patient experienced the following unwanted or unexpected effects: pancytopenia. Cytoxan dosage: 578 Mg; Iv; 1070 Mg; Iv. During the same period patient was treated with ADRIAMYCIN RDF (58 Mg; Iv; 107 Mg; Iv) (View Adriamycin Rdf Review and Adriamycin Rdf Label ). Patient was hospitalized.

6207011-4 | Febrile Neutropenia
Patient was taking Cytoxan (View Usage). Patient had the following side effects: febrile neutropenia on Jan 16, 2009 from UNITED STATES Additional patient health information: Male patient , 71 years of age, was diagnosed with chronic lymphocytic leukaemia and. Cytoxan dosage: 750 Mg/m**2; Every Day; Iv. During the same period patient was treated with RITUXIMAB (375 Mg/m**2; Every Day; Iv) (View Rituximab Review and Rituximab Label ), ADRIAMYCIN RDF (50 Mg/m**2; Everyday; Iv) (View Adriamycin Rdf Review and Adriamycin Rdf Label ), VELCADE (3.2 Mg; Every Day; Iv) (View Velcade Review and Velcade Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), PRILOSEC (View Prilosec Review and Prilosec Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), GEMFIBROZIL (View Gemfibrozil Review and Gemfibrozil Label ), NEURONTIN (View Neurontin Review and Neurontin Label ). Patient was hospitalized.

6206999-5 | Anaphylactic Shock, Hypersensitivity
Adverse event was reported on Dec 10, 2008 by a Female patient taking Cytoxan (View Usage) (Dosage: Iv) was diagnosed with breast cancer (What is breast cancer?) and. Location: UNITED STATES , 68 years of age, After Cytoxan was administered, patient had the following side effects: anaphylactic shock, hypersensitivity. During the same period patient was treated with TAXOTERE (120 Mg;iv) (View Taxotere Review and Taxotere Label ), ALTACE (View Altace Review and Altace Label ), LASIX (View Lasix Review and Lasix Label ), GLUCOPHAGE (View Glucophage Review and Glucophage Label ), HYDROCODONE BITARTRATE (View Hydrocodone Bitartrate Review and Hydrocodone Bitartrate Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ). Patient was hospitalized.

6190214-5 | Body Temperature Fluctuation, Dyspnoea, Headache, Nasal Discomfort, Paraesthesia, Pneumonitis, Red Blood Cell Count Decreased
on Jan 02, 2009 Female patient from UNITED STATES , 59 years of age, was diagnosed with breast cancer (What is breast cancer?) and was treated with Cytoxan (View Usage). Patient experienced the following unwanted or unexpected effects: body temperature fluctuation, dyspnoea, headache (What is headache?), nasal discomfort, paraesthesia, pneumonitis, red blood cell count decreased. Cytoxan dosage: . During the same period patient was treated with DOXORUBICIN HYDROCHLORIDE (Iv) (View Doxorubicin Hydrochloride Review and Doxorubicin Hydrochloride Label ), TAXOTERE (Iv) (View Taxotere Review and Taxotere Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), DAPSONE (View Dapsone Review and Dapsone Label ), PANTOPRAZOLE SODIUM (View Pantoprazole Sodium Review and Pantoprazole Sodium Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), EMEND (View Emend Review and Emend Label ), VALSARTAN (View Valsartan Review and Valsartan Label ).

6170406-1 | Burning Sensation, Pruritus, Rash Maculo-papular, Stevens-johnson Syndrome
on Apr 27, 2009 Female patient from UNITED STATES , 80 years of age, was diagnosed with polyarteritis nodosa, prophylaxis and was treated with Cytoxan (View Usage). Patient had the following side effects: burning sensation, pruritus, rash maculo-papular, stevens-johnson syndrome. Cytoxan dosage: 50mg Po Qd. During the same period patient was treated with BACTRIM DS (1 Tab Po Q Mwf) (View Bactrim Ds Review and Bactrim Ds Label ), RISEDRONATE SODIUM (View Risedronate Sodium Review and Risedronate Sodium Label ), DOCUSATE (View Docusate Review and Docusate Label ), CALCIUM (View Calcium Review and Calcium Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ), METOPROLOL TARTRATE (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ). Patient was hospitalized.

6168586-7 | Diarrhoea, Febrile Neutropenia, Mucosal Inflammation, Proctalgia
Patient was taking Cytoxan (View Usage). After Cytoxan was administered, patient had the following side effects: diarrhoea, febrile neutropenia, mucosal inflammation, proctalgia on Apr 23, 2009 from UNITED STATES Additional patient health information: Female patient , 52 years of age, was diagnosed with breast cancer (What is breast cancer?) and. Cytoxan dosage: Initiated On 27jan09.. During the same period patient was treated with ABRAXANE (View Abraxane Review and Abraxane Label ), AVASTIN (Initiated On 27jan09.) (View Avastin Review and Avastin Label ), ADRIAMYCIN RDF (Initiated On 27jan09.) (View Adriamycin Rdf Review and Adriamycin Rdf Label ), ROZEREM (View Rozerem Review and Rozerem Label ), REGLAN (Achhs) (View Reglan Review and Reglan Label ), LEVOXYL (View Levoxyl Review and Levoxyl Label ), NEULASTA (View Neulasta Review and Neulasta Label ), EMEND (View Emend Review and Emend Label ). Patient was hospitalized.

6160699-9 | Abdominal Pain, Intestinal Perforation
Adverse event was reported on Apr 16, 2009 by a Female patient taking Cytoxan (View Usage) (Dosage: Ist Cycle: 09-mar-2009) was diagnosed with breast cancer (What is breast cancer?) and. Location: UNITED STATES , 65 years of age, Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), intestinal perforation. During the same period patient was treated with TAXOTERE (Soln For Injection First Cycle On 09mar09,) (View Taxotere Review and Taxotere Label ), DECADRON (View Decadron Review and Decadron Label ), BENADRYL (View Benadryl Review and Benadryl Label ), CALCIUM (View Calcium Review and Calcium Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), OXYCODONE HCL (View Oxycodone Hcl Review and Oxycodone Hcl Label ). Patient was hospitalized.

6133956-X | Renal Failure
on Mar 09, 2009 Female patient from UNITED STATES , 48 years of age, weighting 116.8 lb, was diagnosed with acquired haemophilia and was treated with Cytoxan (View Usage). Patient had the following side effects: renal failure. Cytoxan dosage: . Patient was hospitalized.

6110957-9 | Dialysis, Renal Failure
on Mar 09, 2009 Female patient from UNITED STATES , 48 years of age, weighting 116.8 lb, was diagnosed with acquired haemophilia and was treated with Cytoxan (View Usage). After Cytoxan was administered, patient had the following side effects: dialysis (What is dialysis?), renal failure. Cytoxan dosage: . Patient was hospitalized.

6104019-4 | Diarrhoea, Febrile Neutropenia, Mucosal Inflammation, Proctalgia
Patient was taking Cytoxan (View Usage). Patient experienced the following unwanted or unexpected effects: diarrhoea, febrile neutropenia, mucosal inflammation, proctalgia on Mar 03, 2009 from UNITED STATES Additional patient health information: Female patient , 52 years of age, was diagnosed with breast cancer (What is breast cancer?) and. Cytoxan dosage: Initiated On 27jan09.. During the same period patient was treated with ABRAXANE (View Abraxane Review and Abraxane Label ), AVASTIN (Initiated On 27jan09.) (View Avastin Review and Avastin Label ), ADRIAMYCIN PFS (Initiated On 27jan09.) (View Adriamycin Pfs Review and Adriamycin Pfs Label ), ROZEREM (View Rozerem Review and Rozerem Label ), REGLAN (View Reglan Review and Reglan Label ), LEVOXYL (View Levoxyl Review and Levoxyl Label ), NEULASTA (View Neulasta Review and Neulasta Label ), EMEND (View Emend Review and Emend Label ). Patient was hospitalized.

6099048-3 | Diarrhoea, Febrile Neutropenia, Mucosal Inflammation, Proctalgia
Adverse event was reported on Feb 26, 2009 by a Female patient taking Cytoxan (View Usage) (Dosage: Initiated On 27jan09.) was diagnosed with breast cancer (What is breast cancer?) and. Location: UNITED STATES , 52 years of age, Patient had the following side effects: diarrhoea, febrile neutropenia, mucosal inflammation, proctalgia. During the same period patient was treated with ABRAXANE (View Abraxane Review and Abraxane Label ), AVASTIN (Initiated On 27jan09.) (View Avastin Review and Avastin Label ), ADRIAMYCIN PFS (Initiated On 27jan09.) (View Adriamycin Pfs Review and Adriamycin Pfs Label ). Patient was hospitalized.

6091175-X | Gastrointestinal Necrosis, Shock
on Feb 20, 2009 Female patient from UNITED STATES , 52 years of age, was treated with Cytoxan (View Usage). After Cytoxan was administered, patient had the following side effects: gastrointestinal necrosis, shock. Cytoxan dosage: . During the same period patient was treated with TAXOTERE (1 Df = 120-140 Mg/m2) (View Taxotere Review and Taxotere Label ), ADRIAMYCIN PFS (View Adriamycin Pfs Review and Adriamycin Pfs Label ). Patient was hospitalized.

6048382-1 | Deafness Unilateral, Ear Pain, Toothache
on Jan 20, 2009 Female patient from UNITED STATES , 52 years of age, weighting 141.1 lb, was diagnosed with multiple myeloma (What is multiple myeloma?) and was treated with Cytoxan (View Usage). Patient experienced the following unwanted or unexpected effects: deafness unilateral, ear pain, toothache. Cytoxan dosage: . During the same period patient was treated with VELCADE (Days 1, 4, 8 And 11) (View Velcade Review and Velcade Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ).

6037433-6 | Enterococcal Sepsis, Venoocclusive Liver Disease
Patient was taking Cytoxan (View Usage). Patient had the following side effects: enterococcal sepsis, venoocclusive liver disease on Jan 12, 2009 from UNITED STATES Additional patient health information: Male patient , 62 years of age, was diagnosed with acute myeloid leukaemia and. Cytoxan dosage: Formulation: Vial. During the same period patient was treated with VELCADE (Formulation: Inj) (View Velcade Review and Velcade Label ), FLUDARABINE PHOSPHATE (Formulation: Inj) (View Fludarabine Phosphate Review and Fludarabine Phosphate Label ), PROLEUKIN (Formulation: Powder) (View Proleukin Review and Proleukin Label ), THYMOGLOBULIN (Formulation: Powder) (View Thymoglobulin Review and Thymoglobulin Label ).